Tenaya Therapeutics, Inc.
TNYA
$0.88
$0.033.59%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.36% | 20.91% | 20.89% | 16.64% | 20.37% |
| Total Depreciation and Amortization | -12.54% | -11.28% | -1.84% | 23.48% | -4.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -20.02% | -25.55% | -18.67% | -10.41% | -32.40% |
| Change in Net Operating Assets | 186.20% | 30.07% | 151.93% | 5.61% | -54.40% |
| Cash from Operations | 24.19% | 21.36% | 33.89% | 19.36% | 16.13% |
| Capital Expenditure | 67.16% | 85.87% | -94.52% | 32.09% | 48.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 129.71% | 15.87% | 677.96% | 198.50% |
| Cash from Investing | -100.48% | 129.44% | 15.60% | 596.81% | 194.53% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 15,348.81% | 1,125.81% | -- | 7.46% | 1.62% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 15,348.81% | 1,125.81% | -183.51% | 7.46% | 1.62% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,231.91% | 87.26% | 721.44% | 263.01% | 89.28% |